Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank79
3Y CAGR+5.3%
5Y CAGR+134.5%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+5.3%/yr
Annual compound
5Y CAGR
+134.5%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
71x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 2.03 | -33.7% |
| 2024 | 3.06 | +17.7% |
| 2023 | 2.60 | +49.4% |
| 2022 | 1.74 | +39.2% |
| 2021 | 1.25 | +4270.6% |
| 2020 | 0.03 | -97.1% |
| 2019 | 0.98 | +916.7% |
| 2018 | -0.12 | -233.3% |
| 2017 | 0.09 | -59.1% |
| 2016 | 0.22 | - |